Sorafenib: the gold standard therapy in advanced hepatocellular carcinoma and beyond

被引：19

作者：

Gadaleta-Caldarola, Gennaro ^{[1
]}

Divella, Rosa ^{[2
]}

Mazzocca, Antonio ^{[3
,4
]}

Infusino, Stefania ^{[5
]}

Ferraro, Emanuela ^{[6
]}

Filippelli, Gianfranco ^{[5
]}

Daniele, Antonella ^{[2
]}

Sabba, Carlo ^{[3
]}

Abbate, Ines ^{[2
]}

Brandi, Mario ^{[1
]}

机构：

[1] Mons R Dimiccoli Hosp, Div Oncol, I-76121 Barletta Bt, Asl Bat, Italy

[2] Ist Tumori Giovanni Paolo II, Natl Canc Res Ctr, Clin Pathol Lab, I-70100 Bari, Italy

[3] Univ Bari, Sch Med, Interdisciplinary Dept Med, I-70124 Bari, Italy

[4] IRCCS Saverio De Bellis, Natl Inst Digest Dis, I-70013 Bari, Italy

[5] S Francesco di Paola Hosp, Div Oncol, I-87027 Paola Cs, ASP, Italy

[6] Univ Roma La Sapienza, Policlin Umberto 1, Dept Internal Med & Clin Specialties, I-00161 Rome, Italy

来源：

FUTURE ONCOLOGY | 2015年 / 11卷 / 16期

关键词：

HCC; multikinase inhibitors; RAS; RAF; MEK; ERK pathway; sorafenib; PHASE-III TRIAL; RAF/MEK/ERK PATHWAY; ANGIOGENESIS; TARGETS;

D O I：

10.2217/fon.15.161

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：2263 / 2266

页数：4

共 50 条

[1] Molecular targeted therapy of advanced hepatocellular carcinoma beyond sorafenib
Yau, Thomas
Pang, Roberta
Chan, Pierre
Poon, Ronnie T.
[J]. EXPERT OPINION ON PHARMACOTHERAPY, 2010, 11 (13) : 2187 - 2198
[2] Systemic therapy for intermediate and advanced hepatocellular carcinoma: Sorafenib and beyond
Raoul, Jean-Luc
Kudo, Masatoshi
Finn, Richard S.
Edeline, Julien
Reig, Maria
Galle, Peter R.
[J]. CANCER TREATMENT REVIEWS, 2018, 68 : 16 - 24
[3] Treatment of advanced hepatocellular carcinoma: beyond sorafenib
Meyer, Tim
[J]. LANCET GASTROENTEROLOGY & HEPATOLOGY, 2018, 3 (04): : 218 - 220
[4] Systemic therapy for hepatocellular carcinoma: beyond sorafenib
Boland, Patrick
Wu, Jennifer
[J]. CHINESE CLINICAL ONCOLOGY, 2018, 7 (05)
[5] Looking Beyond Sorafenib to Treat Advanced Hepatocellular Carcinoma
Agrawal, Swastik
[J]. JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2016, 6 (04) : 339 - 342
[6] Beyond sorafenib: novel targeted therapies for advanced hepatocellular carcinoma
Zhu, Andrew X.
[J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2010, 19 (05) : 663 - 672
[7] POTENTIAL BIOMARKERS OF SORAFENIB THERAPY IN ADVANCED HEPATOCELLULAR CARCINOMA
Negri, Francesca V.
Dal Bello, Barbara
Campanini, Nicoletta
Rossi, Sandro
Porta, Camillo
Tinelli, Carmine
Poggi, Guido
Missale, Gabriele
Bisagni, Giancarlo
Ardizzoni, Andrea
Silini, Enrico M.
[J]. ANNALS OF ONCOLOGY, 2011, 22 : v20 - v20
[8] Sorafenib and Radiation Therapy for the Treatment of Advanced Hepatocellular Carcinoma
Anne M. Horgan
Laura A. Dawson
Anand Swaminath
Jennifer J. Knox
[J]. Journal of Gastrointestinal Cancer, 2012, 43 (2) : 344 - 348
[9] Sorafenib therapy in advanced hepatocellular carcinoma: the SHARP trial
Rimassa, Lorenza
Santoro, Armando
[J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2009, 9 (06) : 739 - 745
[10] Sorafenib in advanced hepatocellular carcinoma
Sauerbruch, T.
Gonzalez-Carmona, A. M.
Nitschmann, S.
[J]. INTERNIST, 2009, 50 (11): : 1290 - 1292

← 1 2 3 4 5 →